Risk factors for Schistosoma haematobium infection and morbidity in two villages with different transmission patterns in Niger

Acta Tropica

Volumn 115, Issue 1-2, 2010, Pages 84-89

  Garba, Amadou ^a   Pion, Sébastien ^b   Cournil, Amandine ^b   Milet, Jacqueline ^c   Schneider, Dominique ^a,c   Campagne, Gérard ^a   Chippaux, Jean Philippe ^a,c   Boulanger, Denis ^a,b  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Epidemiology; Morbidity; Niger; Parasitology; Schistosoma haematobium; Transmission pattern

Indexed keywords

DISEASE PREVALENCE; DISEASE TRANSMISSION; EPIDEMIOLOGY; INFECTIOUS DISEASE; MORBIDITY; PARASITOLOGY; PUBLIC HEALTH; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER DISEASE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NIGER; PARASITE TRANSMISSION; RISK FACTOR; SCHISTOSOMIASIS HAEMATOBIA; SEASONAL VARIATION; SEX DIFFERENCE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NIGER; RISK FACTORS; RURAL POPULATION; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; URINARY TRACT; YOUNG ADULT;

NIGER [WEST AFRICA];

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

EID: 77953021343     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.02.007     Document Type: Article

References (37)

1. Ault S.K. Intersectoral approaches to neglected diseases. Ann. N.Y. Acad. Sci. 2008, 1136:64-69.
2. Bergquist R., Utzinger J., McManus D.P. Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl. Trop. Dis. 2008, 2:e244.
3. Boulanger D., Warter A., Sellin B., Lindner V., Pierce R.J., Chippaux J.P., Capron A. Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with a homologous challenge. Vaccine 1999, 17:319-326.
4. Brouwer K.C., Ndhlovu P.D., Wagatsuma Y., Munatsi A., Shiff C.J. Epidemiological assessment of Schistosoma haematobium-induced kidney and bladder pathology in rural Zimbabwe. Acta Trop. 2003, 85:339-347.
5. Brouwer K.C., Munatsi A., Ndhlovu P.D., Wagatsuma Y., Shiff C.J. Urinary schistosomiasis in Zimbabwean school children: predictors of morbidity. Afr. Health Sci. 2004, 4:115-118.
6. Campagne G., Garba A., Barkire H., Vera C., Sidiki A., Chippaux J.P. Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel. Trop. Med. Int. Health 2001, 6:24-30.
7. Capron A., Riveau G.J., Bartley P.B., McManus D.P. Prospects for a schistosome vaccine. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002, 2:281-290.
8. Capron A., Riveau G., Capron M., Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol. 2005, 21:143-149.
9. Capron A.R. Immunity to schistosomes. Curr. Opin. Immunol. 1992, 4:419-424.
10. Chandiwana S.K., Woolhouse M.E., Bradley M. Factors affecting the intensity of reinfection with Schistosoma haematobium following treatment with praziquantel. Parasitology 1991, 102(Pt 1):73-83.
11. Clements A.C., Garba A., Sacko M., Toure S., Dembele R., Landoure A., Bosque-Oliva E., Gabrielli A.F., Fenwick A. Mapping the probability of schistosomiasis and associated uncertainty, West Africa. Emerg. Infect. Dis. 2008, 14:1629-1632.
12. Degremont A., Burki A., Burnier E., Schweizer W., Meudt R., Tanner M. Value of ultrasonography in investigating morbidity due to Schistosoma haematobium infection. Lancet 1985, 1:662-665.
13. Doumenge J.P., Mott K.E. Global distribution of schistosomiasis: CEGET/WHO atlas. World Health Stat. Q. 1984, 37:186-199.
14. Ernould J.C., Ba K., Sellin B. The impact of the local water-development programme on the abundance of the intermediate hosts of schistosomiasis in three villages of the Senegal River delta. Ann. Trop. Med. Parasitol. 1999, 93:135-145.
15. Escobedo G., Lopez-Griego L., Morales-Montor J. Neuroimmunoendocrine modulation in the host by helminth parasites: a novel form of host-parasite coevolution?. Neuroimmunomodulation 2009, 16:78-87.
16. Garba A., Toure S., Dembele R., Bosque-Oliva E., Fenwick A. Implementation of national schistosomiasis control programmes in West Africa. Trends Parasitol. 2006, 22:322-326.
17. Garba A., Campagne G., Tassie J.M., Barkire A., Vera C., Sellin B., Chippaux J.P. Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger. Bull. Soc. Pathol. Exot. 2004, 97:7-11.
18. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J., Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349:243-245.
19. Hotez P.J., Fenwick A., Savioli L., Molyneux D.H. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009, 373:1570-1575.
20. Keita A.D., Sangho H., Sacko M., Diarra Z., Simaga S.Y., Traore I. Prevalence of schistomasiasis lesions detected by ultrasonography in children in Molodo, Mali. Gastroenterol. Clin. Biol. 2005, 29:652-655.
21. Kloos H., Rodrigues J.C., Pereira W.R., Velasquez-Melendez G., Loverde P., Oliveira R.C., Gazzinelli A. Combined methods for the study of water contact behavior in a rural schistosomiasis-endemic area in Brazil. Acta Trop. 2006, 97:31-41.
22. Kouriba B., Traore H.A., Dabo A., Sangare L., Guindo H., Keita A.S., Reimert C.M., van Dam G.J., Deelder A.M., Doumbo O., Dessein A.J. Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults. J. Infect. Dis. 2005, 192:2152-2159.
23. Massara C.L., Peixoto S.V., Barros Hda S., Enk M.J., Carvalho Odos S., Schall V. Factors associated with schistosomiasis mansoni in a population from the municipality of Jaboticatubas, State of Minas Gerais, Brazil. Mem. Inst. Oswaldo Cruz. 2004, 99:127-134.
24. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
25. Opara K.N., Udoidung N.I., Ukpong I.G. Genitourinary schistosomiasis among pre-primary schoolchildren in a rural community within the Cross River Basin Nigeria. J. Helminthol. 2007, 81:393-397.
26. Plouvier S., Leroy J.C., Colette J. A propos d'une technique simple de filtration des urines dans le diagnostic de la bilharziose en enquête de masse. Médecine Tropicale 1975, 35:229-230.
27. Poda J.N., Sorgho H., Dianou D., Sawadogo B., Kambou T., Parent G., Sondo B. Parasitological profile of urinary schistosomiasis of the Sourou hydroagricultural complex of Burkina-Faso. Bull. Soc. Pathol. Exot. 2001, 94:21-24.
28. Poggensee G., Feldmeier H. Female genital schistosomiasis: facts and hypotheses. Acta Trop. 2001, 79:193-210.
29. Remoué F., Mani J.C., Pugniere M., Schacht A.M., Capron A., Riveau G. Functional specific binding of testosterone to Schistosoma haematobium 28-kilodalton glutathione S-transferase. Infect. Immun. 2002, 70:601-605.
30. Remoué F., To Van D., Schacht A.M., Picquet M., Garraud O., Vercruysse J., Ly A., Capron A., Riveau G. Gender-dependent specific immune response during chronic human schistosomiasis haematobia. Clin. Exp. Immunol. 2001, 124:62-68.
31. ® System 1995, SAS Institute Inc., Cary, NC, p. 499.
32. Tallo V.L., Carabin H., Alday P.P., Balolong E., Olveda R.M., McGarvey S.T. Is mass treatment the appropriate schistosomiasis elimination strategy?. Bull. World Health Organ. 2008, 86:765-771.
33. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003, 86:125-139.
34. Vennervald B.J., Kenty L., Butterworth A.E., Kariuki C.H., Kadzo H., Ireri E., Amaganga C., Kimani G., Mwatha J., Otedo A., Booth M., Ouma J.H., Dunne D.W. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Trop. Med. Int. Health 2004, 9:461-470.
35. Vera C., Mouchet F., Bremond P., Sidiki A., Sellin E., Sellin B. Natural infection of Bulinus senegalensis by Schistosoma haematobium in a temporary pool focus in Niger: characterization by cercarial emergence patterns. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:62.
36. WHO Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ. Tech. Rep. Ser. 2002, 1-57. 912, i-vi.
37. Yole D.S., Gikuru S.K., Wango E.O., Kithome K., Kiarie S., Limo M. Influence of age of mice on the susceptibility to murine schistosomiasis infection. Afr. J. Health Sci. 2006, 13:47-54.